How Cardiologists’ High Hopes for Two Drugs Were Dashed
By every measure, the drugs were no better than placebos, full data revealed on Saturday. Was it the fault of the design of the studies, or our very hypotheses about heart disease?
Full story
Read the full story at The New York Times - Business ↗
Continue reading this story on The New York Times - Business, the publisher that reported it.
AI tools
Written by AI from the article text. It can make mistakes; check the original story.
